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Abstract
Background: We examined the prevalence of acute kidney injury (AKI) risk factors in the emergency medical unit, generated a
modiﬁed risk assessment tool and tested its ability to predict AKI.
Methods: A total of 1196 patients admitted to medical admission units were assessed for patient-associated AKI risk factors.
Subsequently, 898 patientswere assessed for a limited number of ﬁxed risk factors with the addition of hypotension and sepsis.
This was correlated to AKI episodes.
Results: In the ﬁrst cohort, the prevalence of AKI risk factors was 2.1 ± 2.0 per patient, with a positive relationship between age
and the number of risk factors and a higher number of risk factors in patients ≥65 years. In the second cohort, 12.3% presented
with or developed AKI. Patients with AKI were older and had a higher number of AKI risk factors. In the AKI cohort, 72% of the
patients had two or more AKI risk factors compared with 43% of the cohort with no AKI. When age ≥65 years was added as an
independent risk factor, 84% of those with AKI had two or more AKI risk factors compared with 55% of those with no AKI.
Receiver operating characteristic analysis suggests that the use of common patient-associated knownAKI risk factors performs
no better than age alone as a predictor of AKI.
Conclusions: Detailed assessment of well-established patient-associated AKI risk factors may not facilitate clinicians to
apportion risk. This suggests that additional work is required to develop a more sensitive validated AKI-predictive tool that
would be useful in this clinical setting.
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Introduction
Acute kidney injury (AKI) is a serious and common condition,
which is thought to affect 3–18% of all hospitalized patients [1–4].
It is associated with adverse outcomes and high mortality [4–6]
withan estimated 40 000 plus in patient deaths annually associated
withAKI in theNational Health Service (NHS) inUK alone [7]. It is of
note that evenmild cases of AKI are associated with an increase in
patientmortality [8, 9]. Patients surviving the acute episode are also
at increased risk of progressive chronic kidney disease (CKD) and
death [4, 6, 8]. Recent data suggest that the annual cost of AKI-
related inpatient care in UK amounts to £1.03 billion, which repre-
sents over 1% of the total NHS budget [7].
To date, attempts to develop speciﬁc therapies for AKI have
been unsuccessful. The current emphasis is, therefore, on early
detection and instigation of supportive strategies such as careful
ﬂuid balance, avoidance of nephrotoxic medication and appro-
priate diagnostic investigations, which have been shown to im-
prove AKI outcome [10–12]. In 2009, the National Conﬁdential
Enquiry into Patient Outcome and Death (NCEPOD) [13] report
identiﬁed signiﬁcant deﬁciencies in the management of AKI in
hospitals in the UK. This led to the development and implemen-
tation of strategies such as the use of electronic results reporting
to aid early AKI recognition [14]. In addition to errors in the recog-
nition of patients with AKI, NCEPOD reported signiﬁcant deﬁ-
ciencies in identifying those at risk of developing AKI [13],
highlighting a sizeable proportion of patients in which AKI epi-
sodes are avoidable.Within the NHS in the UK, there is an increas-
ing emphasis on the prevention of avoidable harm, indicating the
need to develop and implement prevention strategies for AKI.
The risk factors for AKI, and the comorbidities that are more
prevalent in patients with AKI, are well established [4, 15–20].
This has led to the recommendation that all emergency admis-
sions should have a formal AKI risk assessment undertaken so
thatmodiﬁable risks factors can be dealt with in a timely fashion.
Acute medical admissions units (MAUs) represent the hospital
entry point for most unscheduled medical admissions in the
UK. Prevention andmanagement of AKI in this settingwill, there-
fore, go a longway to addressing the deﬁciencies and recommen-
dations outlined in the NCEPOD report.
To date, there is a paucity of data that evaluate the prevalence
of AKI risk factors in unselected acute hospital admissions. It is,
therefore, not clear if it would be either appropriate or productive
to carry out a formal complete risk assessment of AKI risk factors
for all patients. Understanding the likely beneﬁt of a comprehen-
sive AKI risk assessment tool is critical given that there are
numerous ‘risk’ assessment tools in place across a range of pre-
dictable conditions that signiﬁcantly add to the work load of
already over-burdened health care workers. Examples include
the national early warning score of acute illness adopted in the
UK, sepsis screening, venous thromboembolism/thrombopro-
phylaxis risk assessment, falls-risk assessment and pressure ulcer
riskassessment. Inorder to informthedebateof themeritsof formal
AKI risk assessment of all acute hospital admissions, this study
aimed to deﬁne the prevalence of AKI-related risk factors in all pa-
tients seen and assessed at MAUs in four hospitals across South
Wales. In addition, we examined the predictive value of a modiﬁed
AKI risk assessment tool for the presence of or the development of
AKI either at presentation or during the ﬁrstweek following hospital
admission in an unselected patient cohort presenting to MAU.
Materials and methods
The ﬁrst phase of the study was performed over a 2-week period
at four MAUs in South East Wales. The contributing hospitals
were located in three separate local health boards: Cwm Taf, An-
eurin Bevan and Cardiff and Vale University Health Boards. The
study was registered as a service evaluation project by each of
the local health boards. Two of the participating hospitals were
district general hospitals [Royal Gwent Hospital (770 beds),
Newport and Prince Charles Hospital (430 beds)], Merthyr Tydﬁl,
serving populations of ∼300 000 and 150 000, respectively. The
two remaining hospitals were the University Hospital of Wales
(1000 beds) and the University Hospital Llandough (480 beds),
teaching hospitals situated in Cardiff serving a combined popula-
tion of 470 000. Information was collected prospectively for all
patients presenting to the MAUs. In addition to basic patient
demographics, data were collected on the presence of any of co-
morbidities that have been highlighted previously as potential
patient-associated ﬁxed risk factors for AKI (Table 1). These
were selected based on a literature review of factors shown to
be increased in patients who have an AKI episode [4, 13, 16, 17,
19, 21, 22].
The second phase of the study was performed over a separate
2-week period in the same units. Basic patient demographics
datawere collected prospectively together with data on the pres-
ence of the most prevalent patient-associated ﬁxed risk factors
for AKI identiﬁed in phase 1 (hypertension, CKD, liver disease,
diabetes, ischaemic heart disease and nephrotoxic medication)
together with any clinical evidence of hypotension or sepsis.
Subsequently for all patients, biochemical results of renal func-
tion prior to, at the point of and up to 1 week following the date
of presentation at MAU were collected to identify all episodes of
AKI. The deﬁnition provided by the Kidney Disease: Improving
Global Outcomes (KDIGO) Clinical Guidelines for AKI was used,
using creatinine (sCr) criteria for identiﬁcation of AKI [23]. Base-
line sCr values for patients were determined through review of
all sCr values taken from the patient during the preceding 12
months. Patients with unknown baseline values had sCr values
charted after AKI resolution, which further enabled approxima-
tion of baseline sCr and conﬁrmation of true AKI. This method
of baseline sCr identiﬁcation is recommended in the recent
KDIGO AKI guidelines [23].
Data were analysed by t-test and one-way ANOVA, and cat-
egorical data compared using a Pearson χ2 test. The discriminat-
ing value and performance of risk assessment was undertaken
using receiver operating characteristic (ROC) analysis to deter-
mine the area under the ROC curve (ROC AUC).
Results
Phase 1
In the ﬁrst phase, data were collected on a total of 1196 patients.
The population of patients represents an older group of patients
with a mean age of 64.8 ± 19.7 years in which 58% of the whole
patient cohort was ≥65 years of age. The distribution of the pro-
portion of patients by age is shown in Figure 1C. There was a pre-
dominance of female patients, which represented 56.7% of the
whole group. There was no difference in the mean age of the fe-
male comparedwith themale patient cohorts (femalesmean age
65.6 ± 21.8 versus male mean age 65.4 ± 18.1 years, P = 0.88). The
mean number of AKI risk factors per patient was 2.06 ± 1.98.
There was a clear relationship between age and the number of
AKI risk factors (Figure 1A). Therewere a signiﬁcantly higher num-
ber of risk factors in patients older than 65 years compared with
those younger than 65 years of age (<65 years AKI-R 1.03 ± 1.4 ver-
sus≥65 years 2.8 ± 2.0, P < 0.00001). Similarly, when comparing the
number of patients in each age groupwho had no AKI risk factors,
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there was a clear negative association (P < 0.00001) with age
(Figure 1B), with almost 80% of patients under the age of 40 having
no AKI risk factors. Althoughwhen comparing the female cohorts
with male cohorts, there was no difference in their ages (females
65.6 ± 21.9 versus males 65.4 ± 18.1 years, P = 0.88), overall there
was a signiﬁcantly lower number of AKI risk factors in the
female group (1.88 ± 1.83) compared with the male cohort (2.34 ±
2.13, P = 0.0004). The presence of two or more AKI risk factors
has been previously reported to predict a cohort of patients at
high risk of developing AKI [24]. The percentage of patients with
two ormore AKI risk factors is shown in Figure 2A, demonstrating
that in each of the age deciles ≥60 years of age, the vast majority
of patients would be ﬂagged as ‘high risk’.
The relevance of individual AKI risk factors is likely to vary ac-
cording to the clinical context, which may be inﬂuenced both by
geography and also by the speciﬁc clinical setting, i.e. MAU ver-
sus other clinical areas. In order to assess the likely impact of
the AKI risk factors in our clinical practice, we determined the
prevalence of each of the individual AKI risk factors. The percent-
age of patients, who had each of the individual AKI risk factors in
thewhole cohort and also in patients aged <65 or >65 years of age
is shown in Figure 2B. In this unselected cohort of patients
attending MAU, the most common AKI risk factors were as
follows: hypertension (38%), treatment with angiotensin con-
verting enzyme inhibitor (ACEi) (28%), treatment with diuretics
(23%), diabetes (22%), CKD (18%) and ischaemic heart disease
(16%). In the patient cohort ≥65 years of age (which represents
58% of the whole cohort), the pattern of distribution of each
of the risk factors was the same although as expected the preva-
lence of each of the risk factors was signiﬁcantly higher: hyper-
tension (52%), treatment with ACEi (38%), treatment with
diuretics (32%), diabetes (27%), CKD (27%) and ischaemic heart
disease (22%).
Table 1. Possible risk factors for AKI that were assessed on admission
Risk factor Description/explanation
Age >65 years
Diabetes mellitus
CKD Stage 3–5 (estimated glomerular ﬁltration rate <60 mL/min/1.73 m2)
Congestive cardiac failure History of congestive cardiac failure or current presentation consistent with acute cardiac failure
Ischaemic heart disease History of previous myocardial infarction or angina
Peripheral vascular disease
Cerebrovascular disease History of cerebrovascular disease/stroke or transient ischaemic event
Peripheral vascular disease Previous intervention for atherosclerotic vascular disease or ongoing symptoms of intermittent
claudication
Solid organ or haematological
malignancy
Active diagnosis of malignancy
Neurological or cognitive
impairment
Residual neurological deﬁcit following previous stroke or known diagnosis of dementia
Liver disease Known history of liver disease
Morbid obesity BMI > 40
AIDS Known conﬁrmed diagnosis of AIDS under specialist care
ACEi/AIIRA Current therapy at the time of admission
Diuretics Current therapy at the time of admission
Non-steroidal anti-inﬂammatory
medication
Current therapy at the time of admission
Hypotensiona Systolic blood pressure <90 mmHg
Evidence of sepsisa The presence of ≥ of the following parameters: temperature <36°C or >38°C, heart rate 90 bpm, white
blood count >12 or <4106/mL, respiratory rate >20 or hyperglycaemia without diabetes
aRisk factors included into second phase of the study only. ACEi, angiotensin converting enzyme inhibitor.
Fig. 1. Age-dependent distribution of AKI risk factors. (A) The average number of
AKI risk factors by indicated age groups with the error bars representing the
standard deviation. (B) The percentage of patients in each age group with no
risk factors and (C) the percentage of the total patient cohort within each age
group.
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Phase 2
In the second period of study, datawere collected on 898 patients.
The basic patient characteristics are given in Table 2. Of these pa-
tients, 12.25% either presented with AKI or developed AKI within
1 week of the initial presentation. The majority of AKI episodes
were AKI stage 1 (82%) with AKI 2 and 3 representing only 16
and 2% of all the AKI episodes, respectively. The patients with
AKIwere signiﬁcantly older (74.6 ± 2.3 versus 63.3 ± 20.5 years, P <
0.00001) than those without AKI and had a signiﬁcantly higher
number of AKI risk factors (2.3 ± 1.3 versus 1.35 ± 1.3, P < 0.0001).
Of those patients with AKI, 69% presented with AKI (commu-
nity acquired, CA-AKI) with the remaining 31% developing AKI
following admission (hospital-acquired, HA-AKI).When compar-
ing the patients with CA-AKI and those with HA-AKI, there was
no signiﬁcant difference in either themean age (73.0 ± 19.6 versus
78.1 ± 112.2 years, P = 0.097) of the patient groups, nor the number
of AKI risk factors (2.25 ± 1.3 versus 2.41 ± 1.44, P = 0.6). In contrast,
when assessing the prevalence of individual risk factors (Figure 3)
there was a higher prevalence of hypertension in the cohort of
HA-AKI (P = 0.015) and a higher prevalence of sepsis in the cohort
presenting with CA-AKI (P = 0.006).
To further evaluate the value of this limited simpliﬁed AKI
risk assessment model, analysis was undertaken of the preva-
lence of AKI in those patients with two or more AKI risk factors.
In the AKI cohort, 73% of the patients had two or more AKI risk
factors comparedwith 43%of the cohortswith noAKI (P < 0.0001).
Previous studies have suggested adoption of age as an independ-
ent risk factor for AKI. Subsequent analysis was made of the in-
ﬂuence of adding either age ≥65 years or age ≥70 years as an
additional risk factor. Using the age cut-off age of 65 years, 84%
of those with AKI have two or more AKI risk factors compared
with 73% in the model where age was not considered as risk
Fig. 2. (A) Age-dependent distribution of patients at high risk of AKI. High risk of AKI was deﬁned as the presence of two or more ﬁxed patient-related AKI risk factors. (B)
Individual AKI risk factor (AKI-R) distribution. (B) Percentage of patients (solid black bars), patients ≥65 years of age (grey bars) or patients <65 years of age (open bars),
positive for each of the individual ﬁxed patient-related AKI risk factors. DM, diabetes mellitus; CKD, chronic kidney disease; BP, hypertension; IHD, ischaemic heart
disease; CCF, congestive cardiac failure; CVD, cerebrovascular disease; PVD, peripheral vascular disease; Ob, morbid obesity; LD, liver disease; Neuro, neurological or
cognitive impairment; AIDS, known diagnosis of AIDS; ACEi, angiotensin converting enzyme inhibitor; D, prescription of diuretic; NSAID, prescription of non-steroidal
anti-inﬂammatory drugs).
Table 2. Comparison of patients with and without documented AKI
AKI
(n = 110)
No AKI
(n = 788)
Age ± standard deviation (years) 74.6 ± 2.3 63.3 ± 20.5
Ave. number of AKI risk factors 2.3 ± 1.3 1.35 ± 1.34
% with ≥2 AKI risk factors 72.7 40.3*
% ≥ AKI risk factors when age ≥65
added as RF
83.6** 55.3*,***
% ≥ AKI risk factors when age ≥70
added as RF
83.6** 52.5*,***
% of patients ≥65 years of age 79.1 52.8*,***
% of patients ≥70 years of age 70.9 45.2*
RF, risk factor.
*P < 0.001 compared to cohort with AKI.
**P < 0.05 compared with AKI % with two or more AKI risk factors.
***P < 0.001 compared with no AKI % with two or more AKI risk factors.
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factor (P = 0.049). Using the age cut-off of 65 years, 55% of those
with no AKI had two or more AKI risk factors, which is signiﬁ-
cantly greater than the model where age was not considered as
a risk factor (P < 0.0001). Increasing the cut-off age to ≥70 years
had no effect on the percentage of patients with two or more
AKI risk factors (84%) and led to only a small non-signiﬁcant
fall in those in the non-AKI cohort with two or more AKI risk fac-
tors (age ≥65 years, AKI risk ≥2 = 55%, age ≥70 years, AKI risk
≥2 = 52%, P = 0.26).
Given the clear association of AKI risk factors with age, we
compared the value of the risk assessment model using numer-
ous variables to the use of age alone as the only risk factor for AKI.
In the AKI cohort, 71% of the patients were ≥70 years of age com-
pared with 84% (P = 0.02) who had ≥ two or more AKI risk factor
(RF) (including age ≥70 years as an RF). Taking a lower age cut-off,
79% of the AKI cohort were ≥65 years of age, which was not sig-
niﬁcantly less that the percentage (84%, P = 0.4) who had two or
more AKI RF (including age of either ≥65 or 75 years as an RF).
Using the lower age cut-off as the sole AKI risk factor, however,
reduced the speciﬁcity, when compared with the use of age ≥70
years alone, as 53% of those with no AKI were in this age group
compared with 45% of those aged ≥70 years (P = 0.002).
Finally, the performance of using known AKI risk factors as a
tool to predict AKI was undertaken (Figure 4). For the whole co-
hort of patients using the AKI risk factors excluding age, the
AUC ROCwas 0.698. Clearly, the sensitivity and speciﬁcity of per-
formance is dependent on the cut-off threshold applied, when a
lowering of the threshold resulting in changing sensitivity and
speciﬁcity in opposite directions. Using a cut-off of >2 risk factors
resulted in a sensitivity of 0.427 and speciﬁcity of 0.198. This com-
pared with an AUC ROC of 0.674 for age alone. Setting an age cut-
off of ≥65 years resulted in a sensitivity of 0.791 and speciﬁcity of
0.528. This suggests either strategy of risk assessment to predict
AKI is limited in their ability to discriminate by poor sensitivity
and speciﬁcity.
For the subgroup that developed hospital-acquired AKI to as-
sess true predictive value, using the AKI risk factors excluding
age, the AUC ROC was 0.709, compared with an AUC ROC of
0.721 for age alone. Using a cut-off of two or more risk factors re-
sulted in a sensitivity of 0.471 and speciﬁcity of 0.198. Setting an
age cut-off of≥65 years of age resulted in a sensitivity of 0.912 and
speciﬁcity of 0.528. In this subgroup, age alone therefore outper-
formed the formal assessment of AKI risk, although the AUC
value suggests that even this is a poor discriminator.
For those who presented to hospital with CA- AKI, the preva-
lence of AKI RF is not truly predictive but rather but a measure of
the strength of association. Using the AKI risk factors excluding
age, the AUC ROC was 0.693, compared with an AUC ROC of
0.653 for age alone. Using a cut-off of >2 risk factors resulted in
a sensitivity of 0.408 and speciﬁcity of 0.198. For this group setting
an age cut-off of ≥65 years of age resulted in a sensitivity of 0.737
and speciﬁcity of 0.528.
Discussion
With the increasing incidence of AKI [25, 26], identifying indivi-
duals at higher risk for developing AKI has become a priority so
that preventative treatment can occur in a timely manner.
Numerous reports have highlighted deﬁciencies in the care of pa-
tients with AKI suggesting that a signiﬁcant proportion of these
cases are both predictable and preventable [7, 27]. In its 2009 re-
port, NCEPODhighlighted deﬁciencies at all levels of patient care,
and recommended ‘Initial clerking of all emergency patients
should include a risk assessment for AKI’ [13].
The risk factors for AKI are well established with multiple
studies comparing the prevalence of potential risk factors in po-
pulations of patients who have developed AKI compared with
control groups with no AKI. Based on these studies, numerous
risk assessment tools have been proposed and generated for spe-
ciﬁc clinical settings such as intensive care units [28], cardiac sur-
gery [29], general surgery [30] or those undergoing radiological
investigations involving intravenous contrast [31]. To date, few
studies have evaluated the predictive value of AKI risk factors
in unselected patients presenting as acute emergencies to the
hospital front door. Acutemedicine is the fastest growingmedic-
al specialty in the UK, and with the majority of all acute admis-
sions now presenting through MAUs, tackling AKI in this
clinical setting provides a unique opportunity to address a large
proportion of the well-reported deﬁciencies in clinical care. Al-
though AKI is considered to be a condition that is predominantly
hospital based, we have previously demonstrated that 67% of all
hospital-managed AKI is acquired in the community [4], further
emphasizing the importance of initiatives aimed at tackling pre-
vention andmanagement at the hospital front door. Assessment
of the acute admission currently involves numerous risk assess-
ment tools to minimize patient harm. In this busy clinical envir-
onment, it is particularly important that a full assessment of the
sensitivity of any new risk assessment tool is undertaken prior to
any recommendation advocating its universal use. Risk factors
for AKI can be divided into chronic patient-related risks and
acute ‘illness- related risks [21]. In order to understand the likely
beneﬁt of a risk assessment tool based on identiﬁcation of the
known AKI risk factors in acute medical admissions, we initially
undertook a study of their prevalence in this clinical setting.
To our knowledge, there have been no previous studies that
have addressed the prevalence of AKI risk factors in all acute
medical admissions. The data clearly demonstrate that the ma-
jority of patients presenting thoughMAUs have a signiﬁcant bur-
den of AKI risk factors. A key ﬁnding was that the burden of AKI
risk factors was directly related to the age of the patients. Signiﬁ-
cantly for those aged ≥65 years, there were on average 2.8 risk
Fig. 3. Distribution of AKI risk factors (AKI-R) in HA- (solid bars) and CA-AKI (open
bars). The data are expressed as a percentage of patients from either cohort. For
signiﬁcance, the appropriate P-value is shown. For each risk factor when no
P-value is listed, the differences were not statistically signiﬁcant.
AKI risk factors in medical emergencies | 677
C
L
IN
IC
A
L
K
ID
N
E
Y
JO
U
R
N
A
L
 at Acquisitions on November 23, 2016
http://ckj.oxfordjournals.org/
Downloaded from 
factors per patient, with only 10% of this patient group having no
risk factors. Although therewere no differences in the ages of the
male and female patient cohorts, the prevalence of AKI risk fac-
tors was signiﬁcantly greater in males compared with females.
These data are therefore consistent with previous studies sug-
gesting that AKI is more common in males [6, 15, 32, 33].
Publications on the prospective predictive value of AKI risk
factors are sparse. In a study of 316 patients by Finlay et al., the
total number of risk factors for an individual patient was strongly
predictive of AKI and patients with two or more risk factors pre-
dicting a 7.1-fold increased risk of having AKI compared with
those with one or no risk factor [24]. Applying this principle,
while noting that we have only assessed ﬁxed chronic factors
and therefore the model is likely to underestimate risk, would
label 63% of the whole cohort as ‘high risk’ and 89% of patients
aged ≥65 years. This suggests that this model of AKI risk assess-
ment may be both time-consuming and seemingly not a sensi-
tive discriminator of AKI risk.
Previous studies comparing the prevalence of AKI risk factors
in patient cohorts who have experienced an episode of AKI have
attempted to stratify the importance of risk factors. These mod-
els have deﬁned age, diabetes and cardiovascular disease as
‘chronic major’ risk factors, while others such as hypertension,
morbid obesity, liver disease, cerebrovascular disease, AIDS and
cancer are classiﬁed as ‘chronic minor’ risk factors [21]. The util-
ity of a risk factor is, in part, dependent on its prevalence in the
population in which the risk is assessed. In our model, we have
collected data on the prevalence of 15 known AKI risk factors.
Of these, the prevalence of 5 of the 15 AKI risk factors was <5%.
The clinical utility and the ease of carrying completion of AKI
risk factor screeningmay therefore be improvedwith a simpliﬁed
model focused on the more prevalent six risk factors (diabetes,
CKD, hypertension, ischaemic heart disease, liver disease and
the prescription of ‘nephrotoxic’ medications). In the second
part of this study, we chose to examine the potential of using
these ﬁxed patient-associated risk factors in combination with
two acute illness-related AKI risk factors, hypotension and sep-
sis. The incidence of AKI of 12.25% was similar to that previously
reported in a similar clinical setting [4]. The true predictive value
of the AKI-associated risks applies to those with HA-AKI. Using
this subgroup and assuming previously published assumptions
that 20–40% of cases of AKI may be predictable and potentially
avoidable [13], the data suggest that in our cohort of 894 patients,
between 7 and 14 patients may have avoidable AKI and therefore
potentially beneﬁt from a highly sensitive prediction tool. In this
study, AKI was associated with a higher incidence of AKI risk fac-
tors. Furthermore, using this simpliﬁed model of risk assess-
ment, the presence of two or more AKI risk factors was
associated with the presence or the development of AKI. There
was also a clear relationship between age and the incidence of
AKI. Given the clear association between age and the number
of AKI risk factors, it is therefore not surprising that using age
alone produced a model that is as effective in predicting AKI as
the more complex model combining comorbidities/ﬁxed risk
factors and ‘illness/acute’ risk factors. The low speciﬁcity of
using either model, however, limits the clinical utility of either
Fig. 4. Receiver operator characteristic curve for AKI prediction score for thewhole cohort of patients using theAKI risk factors excluding age (A) or age alone (B), compared
with the HA-AKI cohort using the AKI risk factors excluding age (C) or age alone (D) and the CA-AKI cohort using the AKI risk factors excluding age (E) or age alone (F). Solid
line: prediction score, dashed line, reference line.
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model. A model using age alone as an assessment tool to predict
HA-AKI is predictive of outcome but with an AUC which at best
can be interpreted as ‘moderate performance’. In a recent publi-
cation, Forni et al. have sought to improve the predictive value of
AKI risk assessment by combining comorbidity, biochemistry
and electronicallymonitored patient physiology to devise a prac-
tical scoring system [34]. This more detailed assessment of pa-
tients produced a tool that was predictive of outcome, although
with a similar moderate AUC performance (0.72), which is in
the same range as our simpliﬁed age-only ‘model’. This further
reinforces that currently there are no accepted validated risk
scores that can be easily applied to clinical practice.
Possible alternative approaches to improve a predictive
model, although beyond the scope of the data collected in this
study,might involve an assessment of the strength of association
of individual factors that then might be applied to a weighted
score rather thanusing each risk as a binary variable. Alternative-
ly, while the inclusion of simple physiological assessment of sep-
sis was not particularly additive in this study, it may be that
different physiological or biochemical parameters reﬂecting
acute illness may be a direction for further evaluation. Informa-
tion from such studies may subsequently allow situational risk
factors to be used in combination with age (which is the best per-
forming factor in our data)-weighted categories of risk from the
condition to generate a more sensitive predictive model. Finally,
alternative suggested approaches include the use of biomarkers
of AKI, and several candidate molecules have been identiﬁed,
particularly in the critically ill [35]. These have shown some
promise although testing to date has been applied to clinical
areas where AKI is common, thus limiting their application as a
broad screening tool. Rather one might anticipate that biomar-
kers may be best used in tandem with a validated predictive
model of AKI risk to increase their sensitivity and speciﬁcity.
Conclusions
In summary, risk prevention is most valuable when it enables
clinicians to match the most appropriate treatment or interven-
tion to a patient’s needs or where it allows public health systems
to allocate resources effectively. Risk prevention can also be a
valuable tool in the clinical research setting, facilitating epi-
demiological studies and patient recruitment onto trials of pre-
ventative interventions. For any risk assessment tool to be of
clinical use and aid physicians in decision-making, it is also
clear that the prevalence of the candidate predictive risk factors
needs to be evaluated in the speciﬁc clinical setting for which its
use is recommended. Although there is clear evidence to support
the inclusion of each of the AKI risk factors selected for this study
as valid candidate predictors, in this speciﬁc clinical setting a de-
tailed analysis of risk factors is not helpful to the clinician in dis-
criminating between patients at high and low risk due to the high
prevalence of these validated risk factors in all patients, and par-
ticularly those aged 65 or above in whom the incidence of AKI is
highest. The data collected in this study suggest a detailed assess-
ment of the riskofAKI inall patients individuallymaynot facilitate
clinicians to apportion risk. As an alternative, while we are still
awaiting anaccepted validated risk assessment tool, one approach
may be to focus resources towards all older patients presenting to
MAU to develop prevention strategies to tacklemodiﬁable risk fac-
tors such as the use of nephrotoxicmedication and hydration, and
early identiﬁcation of AKI throughmonitoring of urine output and
measurement of renal function, which therefore may impact on
the incidence of HA-AKI in this subgroup.
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